Drug Research
Radiopharm Theranostics Partners With Next Generation Preclinical Platform for Therapeutic Radiopharmaceuticals
Radiopharm Theranostics , a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that through its wholly owned subsidiary, Radiopharm Theranostics (USA) Inc., it has entered into a binding agreement to acquire Pharma15 Corporation...
News
What Is The Basic Principle Of ELISA?
Some consider the enzyme-linked immunosorbent assay (ELISA) the gold standard for analytical techniques. In the field of biochemistry and immunology, researchers use it for detecting the presence of specific proteins or antibodies in biological samples.
With many new treatments and...
Drug Research
Japan To See Resurgence In Pharma With $118bn Sales By 2026
One of the most important trade fairs in the pharmaceutical industry will soon be taking place in Japan as it sees a huge resurgence in global trade with companies from the west, especially Switzerland, the USA, and the UK,...
Drug Research
Artificial Blood Brain Model Could Put End To Animal Testing
Uppsala University researchers have created an artificial blood-brain barrier model that can be used to assess the efficacy of anti-body-based medicines while reducing animal experimentation.
The treatment of protein clumps that happen to be prevalent in neurodegenerative illnesses is made...
IT & Data Management
CAGR of 11% Projected In Bioavailability Enhancement Market
Since more biopharmaceutics classification system- BCS II as well as BCS IV molecules are being evaluated in the early stages of development, one of the market reports has signalled that the bioavailability enhancement market is expected to grow at...
IT & Data Management
Wales Life Sciences Spectrum Stamping Its Peerless Authority
Office for Life Sciences- OLS numbers, which were released on December 1, 2022, and cover data till the end of the financial year in 2021, suggest strong growth in income as well as employment when it comes to the...
Drug Research
Duchenne Muscular Dystrophy And Cancer Have A Genetic Link
Scientists from the University of Portsmouth have settled on a novel genetic link between Duchenne muscular dystrophy and cancer.
Duchenne muscular dystrophy, which happens to be a muscle-wasting disease, is known to be caused by mutations when it comes...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.